Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Weighted Average)Tax Rate
Others
Ratios

NewGenIvf (NIVF) Shares Outstanding (Weighted Average): 2021-2024

Historic Shares Outstanding (Weighted Average) for NewGenIvf (NIVF) over the last 4 years, with Dec 2024 value amounting to $358,108.

  • NewGenIvf's Shares Outstanding (Weighted Average) rose 8781.97% to $180.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $180.3 billion, marking a year-over-year increase of 8781.97%. This contributed to the annual value of $358,108 for FY2024, which is 1064.31% up from last year.
  • As of FY2024, NewGenIvf's Shares Outstanding (Weighted Average) stood at $358,108, which was up 1,064.31% from $30,757 recorded in FY2023.
  • In the past 5 years, NewGenIvf's Shares Outstanding (Weighted Average) ranged from a high of $560,000 in FY2021 and a low of $28,797 during FY2022.
  • Over the past 3 years, NewGenIvf's median Shares Outstanding (Weighted Average) value was $30,757 (recorded in 2023), while the average stood at $139,221.
  • As far as peak fluctuations go, NewGenIvf's Shares Outstanding (Weighted Average) crashed by 94.86% in 2022, and later soared by 1,064.31% in 2024.
  • Over the past 4 years, NewGenIvf's Shares Outstanding (Weighted Average) (MRY) stood at $560,000 in 2021, then tumbled by 94.86% to $28,797 in 2022, then increased by 6.81% to $30,757 in 2023, then skyrocketed by 1,064.31% to $358,108 in 2024.
  • Its last three reported values are $358,108 in FY2024, $30,757 for FY2023, and $28,797 during FY2022.